Experimental Gene Therapy Showed Promising Safety and Efficacy in Primate Study of Late-Infantile Batten Disease
Children with late-infantile onset Batten disease (CLN2) may be treated with an enzyme replacement therapy (ERT). However, this therapy cannot reverse the damage or progression children have already experienced. Researchers…